Galectin Therapeutics Inc
GALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133416
In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Galectin Therapeutics Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 60 | 60 | 0 |
| Shares | 7.47M | 7.06M | −407.5K (−5.5%) |
| Value | $12.0M | $9.25M | −$2.79M (−23.2%) |
New holders (5)
Institutions that held Galectin Therapeutics Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Blair William & Co | 40,884 | $54.0K | 0.00% |
| HRT Financial LP | 14,817 | $19.0K | 0.00% |
| CoreCap Advisors, LLC | 9,195 | $12.0K | 0.00% |
| Ronald Blue Trust, Inc. | 7,000 | $11.0K | 0.00% |
| UBS Group AG | 1,776 | $2.00K | 0.00% |
Sold out (5)
Institutions that held Galectin Therapeutics Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Keybank National Association | 100,000 | $161.0K |
| Virtu Financial LLC | 16,261 | $26.0K |
| Dimensional Fund Advisors LP | 11,877 | $19.0K |
| Howard Capital Management Inc. | 10,000 | $16.0K |
| Money Concepts Capital Corp | 1,000 | $2.00K |